Feds Slap Penalties on Shady Global Matchmaking Brokers
Published Date: 8/11/2026
Rule
Summary
Starting September 10, 2026, international marriage brokers in the U.S. must follow new rules or face penalties if they don’t share important info or misuse personal details. This change helps protect people from scams and unfair treatment in matchmaking. Brokers and the public can comment on these rules until the same date, making sure everyone has a say.
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
Civil Penalties: $5,000–$25,000 Per Violation
Starting September 10, 2026, international marriage brokers (IMBs) can be ordered to pay civil penalties of not less than $5,000 and not more than $25,000 for each violation of IMBRA. The rule notes those penalty amounts are subject to adjustment for inflation under 28 CFR 85.5.
IMBRA Cases Adjudicated by OCAHO ALJs
The rule makes IMBRA civil-penalty cases subject to hearings before OCAHO Administrative Law Judges using 28 CFR part 68 procedures. Complaints in IMBRA cases must be signed by the IMBRA enforcement official, may be served at U.S. or foreign business addresses where an IMB does business, do not require the respondent to request a hearing, and final ALJ orders become final agency orders 60 days after entry unless reviewed.
Enforcement Aimed to Deter Exploitation and Fraud
The rule implements procedures to adjudicate IMBRA violations to help deter fraudulent marriages and exploitation of immigrants recruited by international marriage brokers. The Department says these procedures are needed to deter exploitation and enforce IMBRA's requirements.
Longer Response Times and Procedural Changes
In IMBRA cases respondents get more time to respond: an initial answer deadline is extended to a total of 60 days (an extra 30 days beyond the usual 30-day period), and respondents have 20 days (instead of 10) to respond to written motions. IMBRA respondents must provide a U.S. address in their first pleading, and hearings may be held by video teleconference.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-15458, Civil Money Penalty for Actions in Contempt of an Immigration Judge's Proper Exercise of Authority
This notice of proposed rulemaking ("NPRM") would implement a provision of the Immigration and Nationality Act ("INA" or "the Act") that authorizes Immigration Judges, under regulations prescribed by the Attorney General, to sanction by civil money penalty any action (or inaction) in contempt of the proper exercise of their authority by certain individuals. The rule would: define the scope of the contempt authority; provide procedures for contempt findings, penalty determinations, and penalty payment; establish an appellate process; and implement oversight of the use of contempt authority. The rule would also make conforming changes to the grounds for practitioner discipline.
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160, Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-16413, Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
The Drug Enforcement Administration issues this temporary order to schedule O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing O-DSMT in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle O-DSMT.
2026-16375, Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V
The Drug Enforcement Administration proposes to transfer suvorexant ([(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4- diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone), lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)- N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide), and daridorexant ([(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1- yl]-[5-methoxy-2-(triazol-2-yl)phenyl]methanone) from schedule IV to schedule V of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule V controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle suvorexant, lemborexant, and daridorexant.
Previous / Next Documents
Previous: 2026-16289, Amendment of Class D and Class E Airspace and Revocation of Class E Airspace; Muncie and Alexandria, IN
The FAA is updating the airspace rules around Muncie and Alexandria, Indiana, because they’re retiring an old navigation system and canceling some flight procedures. This means changes to how pilots fly in these areas, with new boundaries and updated airport info. These changes kick in on October 29, 2026, and won’t cost anyone extra—just smoother, safer skies!
Next: 2026-16292, Amendment of Class E Airspace; Bedford, IN
This action amends the Class E airspace at Bedford, IN. This action is due to an airspace review conducted due to the decommissioning of the Hoosier very high frequency omnidirectional range (VOR) as part of the VOR Minimum Operational Network (MON) Program. The name of IU Health Bedford Hospital Heliport, Beford, IN, is also being updated to coincide with the FAA's aeronautical database. This action brings the airspace into compliance with FAA orders and supports instrument flight rule (IFR) procedures and operations.